SCHOLAR ROCK HOLDING CORP (SRRK)

Noteworthy Monday Option Activity: LMND, SRRK, EL

Which stocks are moving before the opening bell on Monday?

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Notable Tuesday Option Activity: WGO, LNG, SRRK

Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024

Scholar Rock to Participate in Upcoming Investor Conferences

Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting

Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why Everybody's Talking About Scholar Rock Right Now

Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.

Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants

Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Noteworthy Monday Option Activity: SRRK, UVE, HRTG

Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy

The company is hoping to treat patients with spinal muscular atrophy, a muscle-wasting disease.

Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)

Noteworthy Wednesday Option Activity: PENN, SRRK, COF

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity

Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer

Scholar Rock to Participate in Upcoming Investor Conferences

Noteworthy Tuesday Option Activity: SRRK, AFRM, CSV

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRRK Stock Earnings: Scholar Rock Holding Beats EPS for Q2 2024

SRRK stock results show that Scholar Rock Holding beat analyst estimates for earnings per share the second quarter of 2024.

Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress